Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo compound, E-6011, represents a new treatment targeting programmed cell death protein 1. Initial clinical results from the two programs, KANAb 001 and E-6011, https://mediajx.com/story27920290/text